Medication info

Innoen Linagliptin Tablet 5 mg

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
HK Inno.N Co., Ltd.
Appearance
Red, round, film-coated tablet with a convex shape and an edge on both sides
Packaging
30 tablets - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Expired

MFDS item code 202101799 · Approved 2021.02.23

This product's status changed to Expired on 2026.02.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
HK Inno.N Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty controlling blood sugar levels in patients with type 2 diabetes
View approved original text

This medication can be used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. Initially, it can be administered alone, and if blood sugar control is insufficient, it may be used in combination with other diabetes medications like metformin or sulfonylureas. It can also be used alongside insulin treatment if blood sugar control is challenging. This medication aids in improving blood sugar control at various stages of treatment, thus it can be appropriately used according to the patient's condition. Ultimately, this medication is used for effective management of blood sugar.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used by individuals who are allergic to the active ingredient or any other components. Additionally, it should not be taken by individuals with type 1 diabetes or diabetic ketoacidosis. Caution is needed when taking this medication together with insulin or sulfonylureas, as it could increase the risk of hypoglycemia. Particularly, patients with severely decreased kidney function may face a higher risk of hypoglycemia, and dose adjustment may be necessary. Experience with this medication in heart failure patients is limited, so it should be used cautiously. Also, acute pancreatitis may occur during treatment with this medication, thus if persistent and severe abdominal pain arises, it is essential to stop the medication immediately and consult a doctor. A skin condition called bullous pemphigoid may occur, so if blisters or skin irritation develop, a physician should be notified immediately, and discontinuation of the medication may be necessary. Hypoglycemic symptoms may occur while taking this medication; therefore, it is crucial to be aware of hypoglycemic symptoms, and if symptoms are severe, immediate treatment is required. The use of this medication is not recommended for women who are pregnant or breastfeeding, particularly while breastfeeding, as this medication can be secreted in breast milk. This medication should not be used in children under 10 years of age, and its use in children and adolescents aged 10 to 17 years is not recommended. Elderly patients or those with reduced kidney and liver function can use this medication without special dosage adjustment. In case of overdose, unabsorbed medication should be removed, and symptoms should be monitored, with appropriate treatment provided as necessary. Finally, this medication should be kept out of the reach of children, and transferring to other containers can compromise quality, thus caution is advised.

Side effects

  • Hypoglycemia
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • hypertriglyceridemia
  • hyperlipidemia
  • cough
  • pancreatitis
  • constipation
Show 107 more
  • oral ulcer formation
  • rash
  • bullous pemphigoid
  • severe joint pain with disability
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech impairment
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • viral upper respiratory infection
  • upper respiratory infection
  • dizziness
  • sensory deficit
  • itching
  • insomnia
  • depression
  • hypertension
  • hearing loss
  • erectile dysfunction
  • goiter
  • male pattern baldness
  • hyperhidrosis
  • hair loss
  • anxiety
  • affective disorder
  • contusion
  • bone contusion
  • concussion
  • fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • eye discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • fatty liver disease
  • cholelithiasis
  • hearing loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's efficacy and safety for an extended period.

Appearance and packaging

Appearance

Red, round, film-coated tablet with a convex shape and an edge on both sides

Package unit

30 tablets - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.